4.7 Article

Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia

Related references

Note: Only part of the references are listed.
Letter Immunology

5-HT2a inhibitors for progressive multifocal leukoencephalopathy:: Old drugs for an old disease

Daniele Focosi et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Immunology

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera

Susama Verma et al.

JOURNAL OF INFECTIOUS DISEASES (2007)

Article Rheumatology

Progressive multifocal leukoencephalopathy in systemic lupus erythematosus

Venugopal Govindappa et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)

Article Clinical Neurology

Progressive multifocal leukoencephalopathy in an HTLV-I carrier

Akiko Kimura et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2006)

Article Immunology

Infectious complications associated with alemtuzumab use for lymphoproliferative disorders

Stanley I. Martin et al.

CLINICAL INFECTIOUS DISEASES (2006)

Letter Clinical Neurology

Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up

R Reilmann et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Letter Clinical Neurology

Dramatic improvement in non-AIDS related progressive multifocal leucoencephalophathy

K Aure et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Multidisciplinary Sciences

The human polyomavirus, JCV, uses serotonin receptors to infect cells

GF Elphick et al.

SCIENCE (2004)